Newsroom
July 31, 2024
A report released June 11 by the National Academies of Sciences, Engineering and Medicine (NASEM) provides a working definition of long COVID. Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Rehabilitation Medicine in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San […]
May 2, 2024
The study of a novel oral vaccine that could protect against chlamydia infection received more than $11 million in National Institutes of Health funding through a five-year U01 grant in April 2024. “We are excited about receiving the U01 award because it will enable us to move our basic microbiology and immunology bench research work […]
December 13, 2022
Vaccines for this infection have been challenging to produce SAN ANTONIO (Dec. 13, 2022) — The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease […]
December 9, 2022
Unlike triple threats celebrated in sports and the entertainment world, no one is celebrating the possibility of a triple threat of the flu, respiratory syncytial virus, or RSV and COVID-19. With the winter holidays fast approaching, UT Health San Antonio physicians are encouraging the community to get vaccinated for both the flu and COVID-19, […]
July 15, 2022
Dr. Jason Bowling, Medicine-Infectious Diseases, was an invited guest on this podcast. Listen Now
January 27, 2022
Media contacts: Will Sansom, UT Health San Antonio, (210) 567-2579, sansom@uthscsa.edu Shelley Kofler, University Health, (512) 294-5224, Shelley.Kofler@uhs-sa.com SAN ANTONIO (Jan. 27, 2022) — The University of Texas Health Science Center at San Antonio and clinical partner University Health soon will begin a Phase 1 clinical research study of an HIV vaccine candidate […]
